Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 18.12% is in line with its 5-year average of 17.51%, around the middle of its 5-year range (2.63%–25.06%).
As of the fiscal period ended Wednesday, December 31, 2025. 74.65% above its 12-month average of 10.38%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
18.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
10.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
17.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-1.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-13.16%
CURRENT VS TTM AVG
+74.65%
CURRENT VS 3Y AVG
+22.85%
CURRENT VS 5Y AVG
+3.49%
CURRENT VS 10Y AVG
+138.36%
CURRENT VS 15Y AVG
+1078.14%
CURRENT VS 20Y AVG
+237.70%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+112.43%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$121.16B
Return on Invested Capital (ROIC)
18.12%
TTM Avg
10.38%
3Y Avg
14.75%
5Y Avg
17.51%
Market Cap
$119.53B
Return on Invested Capital (ROIC)
13.71%
TTM Avg
12.85%
3Y Avg
12.25%
5Y Avg
11.92%
Market Cap
$126.60B
Return on Invested Capital (ROIC)
8.53%
TTM Avg
10.14%
3Y Avg
10.34%
5Y Avg
10.08%
Market Cap
$126.79B
Return on Invested Capital (ROIC)
13.90%
TTM Avg
13.75%
3Y Avg
11.92%
5Y Avg
10.17%
Market Cap
$134.62B
Return on Invested Capital (ROIC)
5.72%
TTM Avg
5.90%
3Y Avg
6.54%
5Y Avg
6.70%
Market Cap
$106.51B
Return on Invested Capital (ROIC)
6.13%
TTM Avg
6.11%
3Y Avg
5.46%
5Y Avg
5.53%
Market Cap
$137.47B
Return on Invested Capital (ROIC)
4.72%
TTM Avg
4.17%
3Y Avg
4.46%
5Y Avg
4.93%
Market Cap
$103.60B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
12.56%
3Y Avg
12.53%
5Y Avg
10.40%
Market Cap
$139.86B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
9.06%
3Y Avg
10.60%
5Y Avg
10.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $121.16B | 18.12% | 10.38% | 14.75% | 17.51% |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.53B | 13.71% | 12.85% | 12.25% | 11.92% |
| Stryker Corporation (SYK)vs › | $126.60B | 8.53% | 10.14% | 10.34% | 10.08% |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 13.90% | 13.75% | 11.92% | 10.17% |
| Danaher Corporation (DHR)vs › | $134.62B | 5.72% | 5.90% | 6.54% | 6.70% |
| Medtronic plc (MDT)vs › | $106.51B | 6.13% | 6.11% | 5.46% | 5.53% |
| CVS Health Corp. (CVS)vs › | $137.47B | 4.72% | 4.17% | 4.46% | 4.93% |
| GSK plc (GSK)vs › | $103.60B | 16.61% | 12.56% | 12.53% | 10.40% |
| Pfizer Inc. (PFE)vs › | $139.86B | 8.84% | 9.06% | 10.60% | 10.43% |
| McKesson Corporation (MCK)vs › | $98.45B | 31.48% | 27.39% | 24.73% | 20.68% |
ROIC
18.1%
ROE
22.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 18.12% |
| 2024-12-31 | 2.63% |
| 2023-12-31 | 16.44% |
| 2022-12-31 | 21.81% |
| 2021-12-31 | 20.99% |
| 2020-12-31 | 25.06% |
| 2019-12-31 | 14.39% |
| 2018-12-31 | 12.38% |
| 2017-12-31 | -26.07% |
| 2016-12-31 | 0.41% |
| 2015-12-31 | -22.54% |
| 2014-12-31 | -34.65% |
| 2013-12-31 | -32.83% |
| 2012-12-31 | 0.10% |
| 2011-12-31 | 4.28% |
| 2010-12-31 | -50.16% |
| 2009-12-31 | -35.36% |
| 2008-12-31 | -56.56% |
| 2007-12-31 | -94.45% |
| 2006-12-31 | -26.93% |
| 2005-12-31 | -33.40% |
| 2004-12-31 | -39.52% |
| 2003-12-31 | -44.83% |
| 2002-12-31 | -14.42% |
| 2001-12-31 | -10.77% |
| 2000-12-31 | -4.58% |
| 1999-12-31 | -18.31% |
| 1998-12-31 | 0.00% |
| 1997-12-31 | 0.00% |
| 1996-12-31 | -21.39% |
